Magtrace®
Lymphatic Tracer
A simple solution for breast cancer staging.
Iron Oxide. Sugar. Salt. Water.
Four simple ingredients that together provide a safe and flexible way to stage early breast cancer.
Reduces Unnecessary Surgery
Up to 80% of high-risk DCIS patients can avoid unnecessary lymph node surgery with the Magtrace® tracer. With its 30-day detection window, you only need to proceed with axillary surgery once pathology confirms there’s a benefit.1
Reduces Operating Costs
By avoiding unnecessary SLNB at time of mastectomy, facilities can reduce operating costs up to 24.5% per patient diagnosed with DCIS.1
Improves Workflow
The Magtrace® tracer is simple to store and handle, improving workflow efficiency compared with traditional tracers.
Enables Accurate Procedures
The Magtrace® tracer has a 98% detection rate regardless of when it's injected - non-inferior to the combination of radioisotope and blue dye.2
Eliminates Adverse Reactions
Unlike blue dye, the Magtrace® tracer had no reported cases of anaphylaxis in over 100,000 cases, allowing greater confidence in your patient’s health.2
Offers Increased Flexibility
The Magtrace® tracer can be injected days or minutes ahead of surgery. This offers unrivaled flexibility in scheduling. It can be timed to coincide with a planned hospital visit or when in the operating room under anesthesia, giving the clinician ultimate control.
A Flexible and Accurate Way to Detect the Sentinel Lymph Nodes
- 60 NM organically coated iron oxide particle size is optimized for retention in the sentinel lymph nodes.
- The brown color allows for a single injection dual tracer as it generates visual confirmation in the nodes during surgery.
- The Magtrace® lymphatic tracer is indicated for lumpectomy and mastectomy.
Magtrace® Tracer in Action
Would you like to know more about the Magtrace® tracer for radiation-free Sentinel Lymph Node Biopsy?
Why Magnetic Tracers?
Magnetic tracers have been designed to simplify breast cancer staging, making it more convenient and more widely available, all while never compromising on clinical effectiveness.
Accurate
Clinical trials have shown the Magtrace® tracer to be non-inferior to the combination of radioisotope +/- blue dyes.
Safe
There have been no reported allergic reactions or anaphylaxis in over 100,000 cases.2
Flexible
Inject days or weeks prior to surgery without compromising the efficacy or accuracy.
Radiation-free
Iron oxide. Sugar. Salt. Water. A simple solution to replace radioactive tracers.
Frequently Asked Questions
Is the Magtrace® tracer composed of tiny magnets?
No, the Magtrace® tracer contains many tiny organically coated iron oxide particles that become temporarily magnetized when the Sentimag® probe is near. This facilitates the system’s ability to perform precision localization procedures.
How far in advance of surgery can the Magtrace® tracer be injected?
The Magtrace® tracer can be injected days or as little as 20 minutes before surgery.
Why should my facility consider radiation-free, blue dye-free tracer for Sentinel Lymph Node Biopsy (SLNB)?
The Magtrace® tracer allows your facility to decouple nuclear medicine and surgery. Radiologists can inject the Magtrace® tracer when it’s convenient, and the patient can show up directly to surgical prep the morning of the procedure rather than having to stop at nuclear medicine first. Alternatively, surgeons can also choose to inject the Magtrace® tracer up to 20 minutes before starting surgery, saving the patient from the pain of an added injection. The Magtrace® tracer also enables surgeons to avoid potential risks associated with traditional blue dye such as anaphylaxis and skin necrosis.
What is Delayed Sentinel Lymph Node Biopsy (dSLNB)?
Delayed Sentinel Lymph Node Biopsy is an exciting new procedure that is performed by injecting the Magtrace® tracer in patients with a lower likelihood of having invasive breast cancer. The patient has their mastectomy performed, but does not have a SLNB completed that day. Pathology determines if the patient has invasive or noninvasive cancer in the breast. If non invasive, the patient does not need additional axillary surgery. If it is invasive cancer, the patient may return to surgery for a SLNB. This is a more advanced procedure performed by surgeons familiar with the Sentimag® localization system.
Related Products
Sentimag® Localization Platform
Four techniques in one platform allow for more surgical options than any other non-gamma localization system.
Magseed® Magnetic Marker
A precise 1x5mm marker that becomes detectable when temporarily magnetized by the Sentimag® probe.
HydroMARK™ Breast Biopsy Marker
The HydroMARK™ marker’s exclusive hydrogel technology provides clinicians with unmatched long-term ultrasound visibility.
XPERT® 40 Specimen Radiography System
When you need to identify fine details, in a wide range of specimens, in a short amount of time.
1.Karakatsanis et al. (2019). Effect of preoperative injection of superparamagnetic iron oxide particles on rates of sentinel lymph node dissection in women undergoing surgery for ductal carcinoma in situ (SentiNot study), British Journal of Surgery, Volume 106, Issue 6, May 2019, Pages 720–728
2. Data on file at Endomag